Concepedia

Author

Clémence Ginet

Inserm

Also Known As

C. Ginet, Chantal Desdouets, Clemence Ginet, Clémence Ginet

14

Publications

286

Citations

8

H-Index

27

Concepts

All Affiliations

InsermUniversité Côte d'AzurCentre Hospitalier Universitaire de NiceCentre Antoine LacassagneLa Ligue Contre le Cancer
CG

About

Clémence Ginet is an author at Inserm specializing in medicine, cell biology, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

147

2

Cell Biology

3

3

147

3

Biochemistry

2

2

127

4

Health Sciences

1

1

108

5

Natural Sciences

1

1

19

Clémence Ginet

×

7

Publications

226

Citations

7

H-Index

YearCitations

DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes

Bastien Vergoni, Pierre-Jean Cornejo, Jérôme Gilleron,

Diabetes

2016

108

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib

Ophélie Cassuto, Maeva Dufies, Arnaud Jacquel,

Oncotarget

2012

33

BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia

Valérie Vidal, Guillaume Robert, Laure Goursaud,

Oncotarget

2017

20

Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death

A. Dubois, Clémence Ginet, Nathan Furstoss,

Oncotarget

2016

19

Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib

Caroline Bailleux, Guillaume Robert, Clémence Ginet,

Oncoscience

2014

18

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Thomas Cluzeau, Nathan Furstoss, Coline Savy,

International Journal of Molecular Sciences

2019

15

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway

Guillaume Robert, Valérie Jullian, Arnaud Jacquel,

Oncotarget

2012

13

Page 1